Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Rexinchang Biotechnology Research Institute is an active Chinese biotech company specializing in gut microbiome research. It plays a leading role in organizing major academic events like the China Gut Festival and collaborates with top scientists to advance understanding of the human gastrointestinal tract's role in health and disease. The institute appears to focus primarily on early-stage scientific discovery rather than late-stage clinical or commercial product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Rexinchang Biotechnology Research Institute.